<DOC>
	<DOCNO>NCT03054740</DOCNO>
	<brief_summary>The primary purpose study determine offering vapocoolant ( cold spray ) hospital outpatient prior intravenous catheter ( IV ) insertion increase patient satisfaction IV insertion well determine pain insertion decrease .</brief_summary>
	<brief_title>Vapocoolant Spray Used Prior Intravenous ( IV ) Insertions</brief_title>
	<detailed_description>This single blind interventional study post design use convenience sample patient undergoing Nuclear Medicine Stress Test . The patient selection intervention randomize order ensure high validity study . The interventional treatment use ethyl chloride mist spray manufacture Gebauer Company . The placebo spray use manufacture BioLogic Aqua Research Technologies International Inc . The spray call Nature 's Tears Mist sterile water . The patient 's study require intravenous cannulation ( IV ) access . This painful invasive procedure vapocoolant may confer benefit relief pain .</detailed_description>
	<mesh_term>Ethyl Chloride</mesh_term>
	<criteria>Any outpatient order undergo Nuclear Medicine Stress Test require IV access injection Radiopharmaceuticals If first time patient intravenous catheter insert Any patient may pregnant Any patient breastfeeding Any patient take narcotic , sedative and/or antianxiety medication within 8 hour intervention time . Any patient know diagnosis Raynaud 's Syndrome Carpal Tunnel Syndrome . Any patient allergy hypersensitivity Ethyl Chloride . Any patient age 18 and/or patient age 85 Any patient illiterate Any patient nonEnglish speak Any patient prior experience vapocoolant spray .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Vapocoolant apply prior IV access</keyword>
</DOC>